Skip to content

Efficacy and change in taste by taking SGLT2 inhibitor in patients with type 2 diabetes

Efficacy and change in taste by taking SGLT2 inhibitor in patients with type 2 diabetes - SGLT2 inhibitor and change in taste

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000020157
Enrollment
60
Registered
2015-12-10
Start date
2015-12-10
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

None listed

Sponsors

Nagasaki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Type 2 diabetes

Exclusion criteria

Exclusion criteria: Pregnant women Women who lactaes now

Design outcomes

Primary

MeasureTime frame
BDHQ

Countries

Japan

Contacts

Public ContactIchiro Horie

Nagasaki University Hospital Endocrinology and Metabolism

holy197741@me.com0958197200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026